Get started

PFE

7 day scare windowThe vaccine stocks didn't explode this week as some of us holding the stocks were hoping for. Either the news was priced in for some stocks, or (as I believe is the case for TMO), it needs another catalyst to really jump back into its bullish channel (green channel -- which has a possible target of 530 - 560!) I have updated the cycles for TMO and think it sits a bit better in the updated cycle analysis. TMO is in a tight wedge at the moment, but today or tomorrow should give some indication which side it will break towards. 7 Days Risky Window I hate to say it, but I am seeing this window with a number of stocks since over a month. Seeing now that indexes are over-extended and are just hanging on the stimulus news, I see a potential for a dip over the coming 7 days. The red arrows track this risk. This is only for the near term, as I see TMO bouncing off the 100MA and moving back up as vaccine news and earnings reports near towards January. Good luck!
NYSE:TMOLong
by Karam08
NYSE:PFE Pfizer stock price forecast, Buy Breakout, Target 68.45Pfizer (NYSE: PFE) Trade : Buy Breakout Entry : 42.84 Target : 68.45 (25.61, +59.78%) Stop : 37 (-5.84, -13.63%) Posted on Sunday, December 13, 2020 Note : Pharmaceutical stocks are drawing attention in connection with the COVID-19 (Coronavirus disease 2019) vaccine. Pfizer is one of them. There is no COVID-19 vaccine yet that everyone recognize the efficacy, and it is not known how long it will take. In other words, the prices of pharmaceutical stocks related to the COVID-19 vaccine could not be assured. Pfizer stock prices fell after hitting the resistance line of 42.84. If they strongly break out that price line again, it would be a sign of rise. In that case, the next resistance(target) could be 56.12 and 68.45. If the pharmaceutical market is very strong, we may see 99 or so. It would be better to find opportunities to buy when its stock price breaks out 42.84.
NYSE:PFELong
by Ptrade
6
PFE Pfizer retracement completed. Buy opportunity?I warned you about the retracement in the last post: Look, it`s not trading advice, but the retracement of Pfizer seems completed and now it`s ready for another leg up! They`ve invented the most important vaccine of out time, let`s not diminish their merits. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NYSE:PFELong
by TopgOptions
19
PFE Pfizer GOING LOWERFrom the chart, there are 2 things that concern me : 1 - The bearish cross on the CMF (Chaikin Money Flow Indicator) Chaikin Money Flow (CMF) is a technical analysis indicator used to measure Money Flow Volume over a set period of time. Money Flow Volume is a metric used to measure the buying and selling pressure of a security for single period. CMF then sums Money Flow Volume over a user defined look-back period. Chaikin Money Flow's Value fluctuates between 1 and -1. CMF can be used as a way to further quantify changes in buying and selling pressure and can help to anticipate future changes and therefore trading opportunities. 2 - The market gaps There is still a gap at $34 and market gaps are usually filled. Not even to mention the huge gap that had just occurred after the news of a successful vaccine candidate. PFE has exhibited high volatility during the past few months and each high is always followed by a huge sell of. It's like PFE just can't get ahead. That being said, if you're looking to buy PFE (because viagra isn't going anywhere), I'd be counting on the market gap at $34 as an entry point. Please support me by hitting like, wishing you successful trading! Best Regards, Ev
NYSE:PFEShort
by BlockTechEv
NVAX STOCKS DUMPED, DOWNTREND CONTINUESEarlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less riskier gains and getting out of stocks that do not look promising Other than the above, we have seen strange behavior with stocks of companies in the race. A few examples: PFE Pfizer stock not responding to numerous huge injections from government REGN Regeneron stocks hardly responding to Trump pimp GILD Gilead even FALLING after being the first company world wide to receive FDA approval for remdesivir as a treatment. AZN Astrazeneca in conjunction with Oxford has a trail candidate dead but stocks remain largely unaffected I think NVAX has potential in the long run, long term I remain bullish for the company fundamentally, but not for an investment choice right now. In fact I'd say that no vaccine stock is a good investment right now. The way the market reacts to news is too unpredictable and the future remains uncertain. Hit like if you found this insightful and helpful Thanks, Ev
NASDAQ:NVAX
by BlockTechEv
1
LONG $DGX ER run up ($MRNA $GILD $INO $SPY)see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
NYSE:DGXLong
by WallSt007